Study # 2023-0228

Phase II trial of cemiplimab for the non-operative management of localized dMMR colon cancer

Study Status:

Enrolling

Treatment Agent:

Cemiplimab

Description

Short Title: Phoenix

To learn if cemiplimab can help to control dMMR colon cancer.

Resources and Links

National Clinical Trial Identified Number: NCT05961709

Information and next steps

Disease:

  • Colon

Study Phase:

II

Physician Name:

Department:

Ask a Question